NEWS BULLETIN AUGUST 28, 2026

TOKYO, Oct. 12 -- Statistics Bureau issued the following news: August 28, 2026 No.382 The Statistics Bureau of Japan (SBJ), Ministry of Internal Affairs and Communications, and the Research and Statistics Department (RSD), Ministry of Economy, Trade and Industry jointly and severally released the second tabulation of the 2025 Annual Business Survey (ABS) on July 29, 2026 which was conducted in June, 2025. This survey is conducted in order to identify the structure of all industries, such a...


INSTRUCTIONS BY THE PRIME MINISTER IN RESPONSE TO THE SUSPECTED BALLISTIC MISSILE LAUNCH BY NORTH KOREA (09:24)

TOKYO, Oct. 12 -- Prime Minister and His Cabinet issued the following information: [Provisional translation] * Dedicate maximum effort to gather and analyze information, and provide the public with information in a timely and appropriate manner.* Ensure the safety of aircraft, vessels, and other assets.* Take all possible measures for precaution, including readiness for contingencies. Disclaimer: Curated by HT Syndication....


Clinical Trial: Effects of a dairy ingredient on the oral environment in healthy individuals : a randomized, double-blind, placebo-controlled, crossover superiority trial. (Japan)

Tokyo, Oct. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063245) titled 'Effects of a dairy ingredient on the oral environment in healthy individuals : a randomized, double-blind, placebo-controlled, crossover superiority trial' on Oct. 12. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - Kyushu Unive...


Clinical Trial: Barriers and Facilitators to Physical Activity Among Adult Women with Breast and Gynecologic Cancer Following Primary Treatment: A Scoping Review Using the COM-B Model (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063241) titled 'Barriers and Facilitators to Physical Activity Among Adult Women with Breast and Gynecologic Cancer Following Primary Treatment: A Scoping Review Using the COM-B Model' on Oct. 12. Study Type: Observational Primary Sponsor: Institute - Niigata College of Nursing Condition: Condition - breast and gynecologic cancer (cervical cancer, endometrial cancer, ovarian cancer, e...


Clinical Trial: Validation of sample processing and transport conditions for establishing standard operating procedures (SOPs) for blood component evaluation (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063150) titled 'Validation of blood preservation and transport conditions for standardizing blood component evaluation' on Oct. 12. Study Type: Observational Primary Sponsor: Institute - Kewpie corporation Condition: Condition - healthy subjects Classification by malignancy - Others Genomic information - NO Objective: Narrative objectives1 - To evaluate the effects of sample processi...


Clinical Trial: Pain-Reducing Effect of Adding Sodium Bicarbonate (Meylon) to Local Anesthetic on Injection Pain in Thread Lift Surgery: A Single-Blind Randomized Controlled Trial (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063066) titled 'A Study on Reducing Injection Pain During Local Anesthesia for Thread Lift' on Oct. 12. Study Type: Interventional Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Single blind -participants are blinded Control - No treatment Primary Sponsor: Institute - Tokyo Chuo Beauty Clinic (TCB), Kusatsu Branch Condition: Condition - Injection pain d...


Clinical Trial: Investigation of the Immunomodulatory Effects of Continuous Consumption of the Test Supplement - A Randomized, Double-Blind, Parallel-Group Comparative Trial (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058145) titled 'Investigation of the Immunomodulatory Effects of Continuous Consumption of the Test Supplement - A Randomized, Double-Blind, Parallel-Group Comparative Trial' on Oct. 12. Study Type: Interventional Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo Primary Sponsor: Institute - IMEQRD Co.,...


Clinical Trial: Associations between Health-Related Quality of Life and Upper Limb Function in Women with Breast Cancer-Related Lymphedema (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063244) titled 'Association between Quality of Life and Upper Limb Function in Women with Upper Limb Lymphedema' on Oct. 11. Study Type: Observational Primary Sponsor: Institute - The Jikei University School of Medicine Condition: Condition - Breast cancer Classification by malignancy - Malignancy Genomic information - NO Objective: Narrative objectives1 - The purpose of this study i...


Clinical Trial: Efficacy and Safety of Immunomodulatory Therapies Added to Glucocorticoid-Based Treatment for IgG4-Related Disease: A Systematic Review and Meta-Analysis (Japan)

Tokyo, Oct. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063242) titled 'Benefits and risks of adding immune-modifying medicines to steroid treatment for IgG4-related disease: a review of clinical trials' on Oct. 11. Study Type: Others,meta-analysis etc Primary Sponsor: Institute - Yokohama City University Condition: Condition - IgG4-related disease (IgG4-RD) Classification by malignancy - Others Genomic information - NO Objective: Narrati...


Hubhawks Storms Frankfurt Book Fair 2026, Taking Indian Publishing to the World's Biggest Literary Stage

India, Oct. 10 -- Frankfurt, Germany | October 2026: The world's publishing capitals have converged on Frankfurt, and Hubhawks, one of India's largest integrated book and publishing ecosystems, is making sure India is impossible to miss. From October 7 to 11, 2026, the team is at the heart of the Frankfurt Book Fair, meeting publishers, authors and literary professionals from across the globe and showcasing its vision for the future of Indian publishing.For Hubhawks, this is not just another fai...